BioRem (CVE:BRM) Sets New 1-Year High – Here’s What Happened
by Danessa Lincoln · The Markets DailyBioRem Inc. (CVE:BRM – Get Free Report) shares hit a new 52-week high on Monday . The stock traded as high as C$3.45 and last traded at C$3.35, with a volume of 141939 shares changing hands. The stock had previously closed at C$3.22.
Analyst Upgrades and Downgrades
Separately, Cormark raised shares of BioRem to a “moderate buy” rating in a report on Tuesday, December 17th.
Get Our Latest Analysis on BioRem
BioRem Stock Performance
The company’s fifty day simple moving average is C$3.01 and its 200 day simple moving average is C$2.53. The stock has a market capitalization of C$48.20 million, a P/E ratio of 14.62 and a beta of 0.85. The company has a current ratio of 1.57, a quick ratio of 1.08 and a debt-to-equity ratio of 48.97.
Insider Buying and Selling
In related news, Director Derek Webb sold 120,000 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of C$2.93, for a total value of C$351,600.00. 1.90% of the stock is currently owned by company insiders.
BioRem Company Profile
BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.
See Also
- Five stocks we like better than BioRem
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- What Makes a Stock a Good Dividend Stock?
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Why Invest in 5G? How to Invest in 5G Stocks
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider